Medical Claim Center

04/26/2026

🏈 🤝 ⭐️ 📈

04/23/2026

If you haven’t been involved in this litigation yet, 𝗻𝗼𝘄 𝗶𝘀 𝘁𝗵𝗲 𝘁𝗶𝗺𝗲.

Following the dismissal of Johnson & Johnson’s third bankruptcy attempt, momentum is shifting. Plaintiffs are seeing a wave of favorable verdicts, key rulings are being upheld, and court-ordered mediation is on the horizon. Meanwhile, Johnson & Johnson’s stock remains near record highs even though countless victims continue to suffer, and lose their lives, from ovarian cancer and mesothelioma caused by Johnson’s Baby Powder.

Help us achieve justice in one of the worst cases of corporate malfeasance in history. ⚖️ Join us tomorrow, April 24th for a new to hear post panel updates and more. Register now! ➡️ https://mtmp.com/webinars/johnson-johnson-talc-litigation-post-mtmp-call-to-action/

04/21/2026

Most law firms are paying for leads twice.

Once to acquire them. And again, in staff hours, attorney time, and intake overhead, to figure out if they're actually worth pursuing.

We built something different.

Every claimant we deliver comes with a Proof of Injury file before your team makes a single call. Confirmed diagnosis. Treating physicians on record. Treatment frequency. Injury-related prescriptions. Identity confirmed through our proprietary multi-layer verification technology.

You open the file. You already know there's a case.

No more chasing. No more wasted hours. No more paying for leads that fall apart at intake.

Other companies send leads. We send answers.

If you're managing mass tort leads and you're tired of your team spending 10 to 20 hours per lead, validating contacts that never convert, I'd love to show you what a B1 claimant file actually looks like.

🎯 15 minutes. We'll walk you through a live demo and show you a sample file.

Drop a comment or send us a DM.

04/18/2026

04/17/2026

https://podcasts.apple.com/us/podcast/celebrating-justice/id1739427299?i=1000747331240

Podcast Episode · Celebrating Justice · January 30 · 47m

04/17/2026

🎙️ live at in Vegas 🎉

⚖️ from, Founder of created this premier legal conference to train, connect, and support Plaintiff attorneys

⭐️⭐️⭐️ ‘s Full episode coming soon 🔊

📈

04/16/2026

04/15/2026

A significant development in the ongoing NEC baby formula litigation is capturing attention across the plaintiffs’ bar.

An Illinois jury has awarded $70 million to four families in a case against Abbott Laboratories, involving its preterm infant formula (Similac). The verdict includes $53 million in compensatory damages and $17 million in punitive damages, underscoring growing jury sensitivity to these claims.

This case adds to a series of high-value verdicts in NEC litigation, where plaintiffs allege that cow’s milk-based formulas increase the risk of necrotizing enterocolitis (NEC) in premature infants—a serious and potentially fatal condition.

With hundreds of cases already pending in federal MDL and additional actions progressing in state courts, the trajectory of this litigation continues to evolve rapidly.

As bellwether trials approach and verdicts gain traction, this space remains one to watch closely for both case valuation trends and broader settlement implications.

💬 Are you seeing similar momentum across other pharmaceutical or product liability MDLs in 2026?